• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema.

作者信息

Caballero T, Maurer M, Longhurst H J, Aberer W, Bouillet L, Fabien V

机构信息

Allergy Department, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network on Rare Diseases (CIBERER, U754), Madrid, Spain.

Department of Dermatology and Allergy, Allergie-Centrum- Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.

出版信息

J Investig Allergol Clin Immunol. 2016;26(6):383-386. doi: 10.18176/jiaci.0102.

DOI:10.18176/jiaci.0102
PMID:27996949
Abstract
摘要

相似文献

1
Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema.遗传性血管性水肿患者血管性水肿发作的触发因素和前驱症状
J Investig Allergol Clin Immunol. 2016;26(6):383-386. doi: 10.18176/jiaci.0102.
2
Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world setting.用依卡替班治疗遗传性血管性水肿：临床试验中的疗效与真实世界中的有效性。
Allergy Asthma Proc. 2014 Sep-Oct;35(5):377-81. doi: 10.2500/aap.2014.35.3780. Epub 2014 Aug 6.
3
Bradykinin B2 receptor antagonist off label use in short-term prophylaxis in hereditary angioedema.缓激肽B2受体拮抗剂在遗传性血管性水肿短期预防中的超说明书用药
Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):653-9. doi: 10.1177/039463201402700423.
4
Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.切换至艾卡替班特治疗高疾病活动度遗传性血管性水肿患者：病例报告。
Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):269-73. doi: 10.1177/039463201202500130.
5
Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3.在FAST-3的对照期和开放标签延长期中，依卡替班用于治疗遗传性血管性水肿发作的研究
Int Arch Allergy Immunol. 2015;168(1):44-55. doi: 10.1159/000441060. Epub 2015 Nov 11.
6
The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries.Icatibant 结局调查：来自六个欧洲国家的遗传性血管性水肿管理经验。
J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1214-1222. doi: 10.1111/jdv.14251. Epub 2017 Jun 1.
7
Icatibant as acute treatment for hereditary angioedema in adults.依卡替班用于成人遗传性血管性水肿的急性治疗。
Expert Rev Clin Pharmacol. 2016 Jun;9(6):779-88. doi: 10.1080/17512433.2016.1182425. Epub 2016 May 13.
8
Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings.儿科医生诊断出患有儿童期遗传性血管性水肿的患者很少：艾替班特结果调查结果。
J Allergy Clin Immunol Pract. 2019 Mar;7(3):1078-1080. doi: 10.1016/j.jaip.2018.07.047. Epub 2018 Aug 28.
9
Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.依替巴肽治疗遗传性血管性水肿发作的重复治疗：FAST-2 开放性研究。
Allergy. 2013 Nov;68(11):1452-9. doi: 10.1111/all.12244. Epub 2013 Sep 21.
10
Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study.依卡替班，一种缓激肽受体2抑制剂，用于遗传性血管性水肿发作：前瞻性实验单队列研究。
Sao Paulo Med J. 2014;132(5):261-5. doi: 10.1590/1516-3180.2014.1325652. Epub 2014 Jul 22.

引用本文的文献

1
Attack frequency and associated factors in hereditary angioedema patients: a single-centre experience.遗传性血管性水肿患者的发作频率及相关因素：单中心经验
Postepy Dermatol Alergol. 2025 Feb;42(1):75-82. doi: 10.5114/ada.2024.144488. Epub 2024 Nov 6.
2
Hereditary angioedema diagnosis evaluation score (HADES): A new clinical scoring system for predicting hereditary angioedema with C1 inhibitor deficiency.遗传性血管性水肿诊断评估评分（HADES）：一种用于预测C1抑制剂缺乏型遗传性血管性水肿的新型临床评分系统。
J Allergy Clin Immunol Glob. 2025 Jan 17;4(2):100414. doi: 10.1016/j.jacig.2025.100414. eCollection 2025 May.
3
A real-world study of hereditary angioedema patients due to C1 inhibitor deficiency treated with danazol in the Brazilian Public Health System.
在巴西公共卫生系统中，对因C1抑制剂缺乏而接受达那唑治疗的遗传性血管性水肿患者进行的一项真实世界研究。
Front Med (Lausanne). 2024 Sep 6;11:1343547. doi: 10.3389/fmed.2024.1343547. eCollection 2024.
4
Case Report: Early presentation of hereditary angioedema symptoms in a 2-year-old boy.病例报告：一名2岁男孩遗传性血管性水肿症状的早期表现。
Front Pediatr. 2024 Jun 24;12:1408110. doi: 10.3389/fped.2024.1408110. eCollection 2024.
5
Mast cell degranulation and bradykinin-induced angioedema - searching for the missing link.肥大细胞脱颗粒与缓激肽诱导的血管性水肿——寻找缺失的环节。
Front Immunol. 2024 May 15;15:1399459. doi: 10.3389/fimmu.2024.1399459. eCollection 2024.
6
[Hereditary angioedema due to C1-inhibitor deficiency, a national disease management programme].[C1抑制剂缺乏所致遗传性血管性水肿，一项全国性疾病管理计划]
Wien Klin Wochenschr. 2023 Nov;135(Suppl 8):785-798. doi: 10.1007/s00508-023-02298-x. Epub 2023 Dec 8.
7
The multifactorial impact of receiving a hereditary angioedema diagnosis.遗传性血管性水肿诊断的多因素影响。
World Allergy Organ J. 2023 Jun 30;16(6):100792. doi: 10.1016/j.waojou.2023.100792. eCollection 2023 Jun.
8
Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor.管理C1酯酶抑制剂水平正常的遗传性血管性水肿患者的诊断、治疗和疾病负担
J Asthma Allergy. 2023 Apr 22;16:447-460. doi: 10.2147/JAA.S398333. eCollection 2023.
9
Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema.遗传性血管性水肿生活质量问卷的内容验证和心理计量学评估
J Patient Rep Outcomes. 2023 Apr 3;7(1):33. doi: 10.1186/s41687-023-00576-w.
10
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation.遗传性血管性水肿：过度接触激活的临床表现。
Semin Thromb Hemost. 2024 Oct;50(7):978-988. doi: 10.1055/s-0042-1758820. Epub 2022 Nov 23.